Additionally, most currently available therapeutic inhibitors of renin-angiotensin-aldosterone system are teratogenic and fetotoxic, precluding their use to treat preeclampsia (Alwan et al., 2005; Alwasel et al., 2010; Ferreira et al., 2010). This evidence concerns the gene REN and preeclampsia.